Real-world cardiovascular outcomes with novel anti-androgen agents in prostate cancer patients.

e16510Background: Abiraterone use is associated with significant cardiovascular (CV) morbidity in clinical trials, but the magnitude of this morbidity in contemporary US prostate cancer (PC) popula...